Dr. John Cush RheumNow
5 years 10 months ago
#BestACR20Tweets
RT @ejdein1 : Draft #ACR20 Rx Recs for RA: on max tolerated MTX - add bio or tsDMARD conditional recommendation over triple therapy (MTX, HCQ, SSZ). @RheumNow. https://t.co/uff7Vj0iKA https://t.co/Tquq7FN86y
Dr. John Cush RheumNow
5 years 10 months ago
#BestACR20Tweets
RT @ejdein1 : Draft #ACR20 Rx Recs for RA: discontinue MTX over biologic or tsDMARD in "patients that strongly want to discontinue", conditional recommendation supported by SEAM-RA Abst#939 @RheumNow https://t.co/2Ozvkq4Rjo https://t.co/xlbKAItFzN
Dr. John Cush RheumNow
5 years 10 months ago
Check out our latest article from Dr. Janet Pope ( @Janetbirdope)
How are RA patients doing using telemedicine/virtual care?
https://t.co/YffT28OwgY https://t.co/xnAe3lKL8W
Dr. John Cush RheumNow
5 years 10 months ago
(if this is true) Shame on @expressScripts and forcing money driven biologic changes (from secukinumab to ixekizumab) upon patients and doctors. This is soooo wrong! https://t.co/DYKSItCbYL
Dr. John Cush RheumNow
5 years 10 months ago
#BestACR20Tweets
RT @DrMiniDey : Study on #telehealth in #rheumatology patients in the US finds those with #comorbidities and high disease activity are most likely to take up remote consults.
Abs#1962 #ACR20 @RheumNow
https://t.co/8USU39mTPk https://t.co/ioT1b1x4IO
The results of the long awaited PIANO study have been reported in the journal Gastroenterology, showing that pregnant women with IBD may safely receive biologic or thiopurine therapy throughout the pregnancy without substantial added risk to the unborn or mother.
Dr. John Cush RheumNow
5 years 10 months ago
Pipeline Therapies for Urate Lowering: Dr. Michael Pillinger
#ACR20
https://t.co/M3ahjjZWK8 https://t.co/Ipc0nowK2t
Dr. John Cush RheumNow
5 years 10 months ago
Check out Dr. Kathyrn Dao's blog experience. A rheumatology researcher signs up for the COVID-19 vaccine! https://t.co/B9Wsvo7DJH
Colchicine, the old gout drug often cited as a cheap anti-inflammatory, hasn't been such a good deal since FDA approval, a study in JAMA Internal Medicine showed.
Dr. John Cush RheumNow
5 years 10 months ago
#BestACR20Tweets
RT @MeralElRamahiMD :Conditional recommendation to add bDMARD or tsDMARD in RA pts on maximally tolerated dose of MTX over adding HCQ+SSZ (triple therapy) per draft recommendation of new ACR RA treatment guidelines. #ACR20 @ElaineHusniMD https://t.co/tCAbgYi3h0 https://t.co/AoEOJd3pQh
Dr. John Cush RheumNow
5 years 10 months ago
How COVID Changed Work: Drs. Rachel Tate, Cassie Calabrese and Mary Hinojos Mamut #ACR20
https://t.co/jyM8NPicZF https://t.co/6zA7Kmgzwi
Dr. John Cush RheumNow
5 years 10 months ago
Measuring Disease Activity in Psoriatic Arthritis: Dr. Eric Ruderman ( @JointMD) looks at several abstracts that focus on disease activity measurement in psoriatic arthritis presented at the #ACR20 meeting.
https://t.co/Tu58NDbc51 https://t.co/RGwON4gu7w
Dr. John Cush RheumNow
5 years 10 months ago
#BestACR20Tweets
RT @ejdein1 : Draft #ACR20 Rx Recs for RA: Treatment recommendations for Hepatitis B - highest risk is for RTX for reactivation! @RheumNow. https://t.co/JvYm9Ii6PV https://t.co/qjXBuzUug6
Dr. John Cush RheumNow
5 years 10 months ago
ACR has released 2 free powerpoint slide decks featuring select RA and SLE abstracts from #ACR20 (a 3rd late-breaking slide deck is yet to come!). Download here>> https://t.co/CiNH0xfs7J
Peter Nash drpnash
5 years 10 months ago
Cytokine Storm | NEJM https://t.co/sNNKtdPYw8 #cyokinestorm #inflammasomopathy nice review underlying a number of our “auto inflammatory “ funny seronegs with gut rash and other odd features?
